Afinitor everolimus regulatory update

Novartis said FDA approved an sNDA for Afinitor everolimus to treat subependymal giant cell astrocytomas (SEGA) associated with tuberous sclerosis (TS). In July, Novartis submitted an MAA in the EU fo...